Investors who purchased or acquired Ardent Health, Inc. (NYSE: ARDT) securities between July 18, 2024, and November 12, 2025, have until March 9, 2026, to file a lead plaintiff motion in an ongoing class action lawsuit. The case, handled by Glancy Prongay Wolke & Rotter LLP, alleges securities fraud during this period.
Shareholders who suffered losses during the specified timeframe are encouraged to contact the law firm to discuss their rights and potential participation in the litigation.
**Why this matters**
Filing a lead plaintiff motion by the deadline is crucial for investors seeking to have a voice in the lawsuit and potentially recover losses related to the alleged securities violations. Missing the deadline may result in losing the opportunity to participate in the case.